SNHG32 and alveolar rhabdomyosarcoma: It is presently unknown whether the significantly different percentages of G8+/noggin+/BF+ cells in RC13 and RD RMS cells in vitro reflects the aggressiveness of ARMS and ERMS tumors in vivo.